Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)
Clinical trial NCT00599131 · TERMINATED
Trial details
- NCT number
- NCT00599131
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-07-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.